2) Rudnick SA et al: High dose cytosine arabinoside (HDARAC) in refractory acute leukemia. Cancer 44: 1189∼1193, 1979
3) Herzig RH et al: High-dose cytosine arabinoside therapy for refractory leukemia. Blood 62: 361∼369, 1983
4) van Prooijen HC et al: The use of intermediate dose cytosine arabinoside (ID AraC) in the treatment of acute non-lymphocytic leukaemia in relapse. Br J Haematol 57: 291∼299, 1984
5) Capizzi RL, et al: Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood 63: 694∼700, 1984